Pathophysiology of coronary thrombosis: Role of plaque rupture and plaque erosion

Progress in Cardiovascular Diseases

Volumn 44, Issue 5, 2002, Pages 357-368

  Shah, Prediman K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROTIC PLAQUE; CALCIFICATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; DISEASE SEVERITY; EROSION; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; INFLAMMATION; LIPID COMPOSITION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; REVIEW; RUPTURE;

EID: 0036090575     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2002.123473     Document Type: Article

References (141)

1. Pathophysiology of acute coronary syndromes
2. Coronary plaque disruption
3. Molecular bases of the acute coronary syndromes
4. 50th Anniversary historical article. Acute coronary syndromes: The degree and morphology of coronary stenoses
5. Plaque disruption and thrombosis: Potential role of inflammation and infection
6. Plaque rupture and plaque erosion
7. Current concepts of the pathogenesis of the acute coronary syndromes
8. Relationship between coronary thrombosis and myocardial infarction
9. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction
10. Coronary arteriographic findings in acute transmural myocardial infarction
11. Coronary arteriographic findings soon after non-Q-wave myocardial infarction
12. Significance of the angiographic morphology of localized coronary stenoses: Histopathologic correlations
13. Coronary angioscopy in patients with unstable angina pectoris
14. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease
15. Platelet aggregation in partially obstructed vessels and its elimination with aspirin
16. Platelet aggregation in stenosed coronary or cerebral arteries: A mechanism for sudden death?
17. The pathological basis and microanatomy of occlusive thrombus formation in human coronary arteries
18. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death
19. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi
20. Angiographic morphology and the pathogenesis of unstable angina pectoris
21. Coronary angiographic morphology in myocardial infarction: A link between the pathogenesis of unstable angina and myocardial infarction
22. Anatomic-physiologic links between acute coronary syndromes
23. Pathogenesis of coronary thrombosis, intramural and intraluminal hemorrhage
24. The pathogenesis of coronary plaques, thromboses, and hemorrhages: An evaluative review
25. Atherosclerosis - A general survey and synthesis
26. Arteriographic anatomy and mechanisms of myocardial ischemia in unstable angina
27. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques
28. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle cell content
29. Relation of plaque lipid composition and morphology to the stability of human aortic plaques
30. Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: Span-wise variations
31. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture
32. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes
33. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: An intravascular ultrasound study
34. Atherosclerotic plaque caps are locally weakened when macrophages density is increased
35. Neovascularization in human coronary atherosclerotic lesions
36. Neovascularization in atherectomy specimens from patients with unstable angina: Implications for pathogenesis of unstable angina
37. Development of the lipid-rich core in human atherosclerosis
38. Lipid and cellular constituents of unstable human aortic plaques
39. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels
40. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation
41. Mechanical properties of model atherosclerotic lesion lipid pools
42. The impact of calcification on the biomechanical stability of atherosclerotic plaques
43. Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture
44. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques
45. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity
46. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions
47. Stimulation of platelets and endothelial cells by mildly oxidized LDL proceeds through activation of lysophosphatidic acid receptors and the Rho/Rho-kinase pathway. Inhibition by lovastatin
48. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
49. The mast cell - A potential link between inflammation and cellular cholesterol deposition in atherogenesis
50. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction
51. Chymase-containing mast cells in human arterial intima: Implications for atherosclerotic disease
52. Mast cell infiltration in acute coronary syndromes: Implications for plaque rupture
53. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery
54. Hypothesis: Vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis
55. Neovascularization and coronary atherosclerotic plaque: Cinematographic localization and quantitative histologic analysis
56. Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction
57. Blood flow through vasa vasorum of coronary arteries in atherosclerotic monkeys
58. The vasa vasorum of the arteries
59. Enhanced coronary vasa vasorum neovascularization in experimental hypercholester-olemia
60. Angiographic evoluation of coronary artery morphology in unstable angina
61. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?
62. Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe
63. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography
64. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apoli-poprotein B
65. Does the presence and site of myocardial ischemia on perfusion scintigraphy predict the occurrence and site of future myocardial infarction in patients with stable coronary artery disease?
66. Plaque size, vessel size and plaque vulnerability: Bigger may not be better
67. Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: An intravascular ultrasound study in vivo
68. Mechanical and structural characteristics of vulnerable plaques: Analysis by coronary angioscopy and intravascular ultrasound
69. The pathophysiology of acute coronary syndrome
70. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization
71. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
72. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina
73. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis
74. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions
75. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases
76. Oxidized low-density lipoprotein regulates matrix metalloprotein-ase- 9 and its tissue inhibitor in human monocytederived macrophages
77. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: Evidence for activation by proinflammatory mediators
78. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase
79. Human mono-cyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloprotein-ases and implications for plaque rupture
80. Role of inflammation and metalloproteinases in plaque disruption and thrombosis
81. Evidence for increased collagenolysis by interstitial collagenases-1 and - 3 in vulnerable human atheromatous plaques
82. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture
83. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions
84. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression
85. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: Implications for tubule formation
86. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: A role for CD40 signaling in plaque rupture?
87. Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque
88. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells
89. Cystatin C deficiency in human atherosclerosis and aortic aneurysms
90. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse
91. ApoE knockout mice expressing human matrix metallo-proteinase- 1 in macrophages have less advanced atherosclerosis
92. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
93. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability
94. Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits
95. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis
96. Co-expression of p53 and MDM2 in human atherosclerosis: Implications for the regulation of cellularity of atherosclerotic lesions
97. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture
98. Atherogenic lipoproteins, oxidative stress, and cell death
99. Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: Potential role in oxidized LDL-induced apoptosis
100. Apoptosis in the vascular wall and atherosclerosis
101. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells
102. Apoptosis in atherosclerosis: Beneficial or detrimental?
103. The role of apoptosis in vascular disease
104. Apoptosis in the vasculature: Mechanisms and functional importance
105. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta
106. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse
107. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model
108. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice
109. Animal model that mimics atherosclerotic plaque rupture
110. Circadian variation and triggers of onset of acute cardiovascular disease
111. Triggering and hourly variation of onset of arterial thrombosis
112. Pathophysiology and triggers of acute myocardial infarction: Clinical implications
113. Sudden cardiac death. Support for a role of triggering in causation
114. Increased particulate air pollution and the triggering of myocardial infarction
115. Triggering myocardial infarction by marijuana
116. Triggering of cardiac events by sexual activity: Findings from a case-crossover analysis
117. Circadian variation and triggering of acute coronary events
118. Multiple complex coronary plaques in patients with acute myocardial infarction
119. Smoking increases tissue factor expression in atherosclerotic plaques: Implications for plaque thrombogenicity
120. Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression
121. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly
122. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death
123. Circulating tissue factor and thrombosis
124. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
125. Atherosclerosis. Potential targets for stabilization and regression
126. Plaque stabilization: A mechanism for the beneficial effect of lipid-lowering therapies in angiography studies
127. Pathophysiology of plaque rupture and the concept of plaque stabilization
128. Plaque disruption and coronary thrombosis: New insight into pathogenesis and prevention
129. Plaque stabilization: The role of lipid lowering
130. Vulnerable plaque: Pathobiology and clinical implications
131. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization
132. Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheroma
133. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of Macrophages expressing matrix metallo- proteinases and tissue factor in vivo and in vitro
134. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanable heritable hyperlipidemic rabbits
135. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholes-terolemic rabbits
136. Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice
137. High-dose recombinant apolipoprotein a-i(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice: Potential implications for acute plaque stabilization
138. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization
139. Exploiting the vascular protective effects of HDL and its apolipoproteins: An idea whose time for testing is here
140. Exploiting the vascular protective effects of HDL and its apolipoproteins: An idea whose time for testing is here
141. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor